Log In
Print
BCIQ
Print
Print this Print this
 

Panobinostat (LBH589)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionOral pan-deacetylase (DAC) inhibitor
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today